Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure – Reuters India

Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure – Reuters India

Eli Lilly and Co on Tuesday aimed to ease investor concerns about its COVID-19 antibody treatment after a trial of the therapy failed to show a benefit in hospitalized patients.

Read More…

You May Also Like